Comparative clinical efficacy and safety of rileptid and rispolept in the treatment of patients with acute schizophrenia
Suggested citation:
Altynbekov SA. [Comparative clinical efficacy and safety of rileptid and rispolept in the treatment of patients with acute schizophrenia]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2015;(6):52-54. Russian
Abstract
A comparative study was carried out in a group of 60 schizophrenic patients of the effects of antipsychotic drug risperidone and its generic form rileptid authorized for clinical use in the Republic of Kazakhstan. They were found to exert similar effects in alleviating acute psychotic states in patients with schizophrenia.
DOI: http://dx.doi.org/10.24411/1560-957X-2015-1%25x
Article Metrics
Metrics Loading ...
Metrics powered by PLOS ALM